胃肠道神经内分泌肿瘤的诊断和治疗进展

摘要/Abstract

摘要：胃肠道神经内分泌肿瘤（GINET）是起源于消化道肽能神经元和神经内分泌细胞的一类肿瘤，能产生肽类激素，引起类癌综合征，但临床上出现典型症状者较少见。由于诊断技术及对该病认识的进步，发病率有所上升。目前治疗措施是以手术切除为主，联合化疗、靶向治疗的综合疗法。

盛能全；杨逸；王志刚. 胃肠道神经内分泌肿瘤的诊断和治疗进展[J]. 国际肿瘤学杂志, 2015, 42(4): 309-312.

Sheng-Neng-Quan-；Yang-Yi-；Wang-Zhi-Gang. 10.3760/cma.j.issn.1673-422X.2015.04.019[J]. Journal of International Oncology, 2015, 42(4): 309-312.

［1］ Oberndorfer S. Karzinoide tumoren des dunndarms［J］. Frankf Z Pathol, 1907, 1: 426432. ［2］ Modlin IM, Lye KD, Kidd M. A 5decade annlysis of 13,715 carcinoid tumors［J］. Cancer, 2003, 97(4): 934959. ［3］ Lawrence B, Gustafsson BI, Chan A, et al. The epidemiology of gastroenteropancreatic neuroendocrine tumors［J］. Endocrinol Metab Clin North Am, 2011, 40(1): 118. ［4］ Ito T, Igarashi H, Nakamura K, et al. Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: a nationwide survey analysis［J］. J Gastroenterol, 2015, 50(1): 5864. ［5］ Tsai HJ, Wu CC, Tsai CR, et al. The epidemiology of neuroendocrine tumors in Taiwan: a nationwide cancer registrybased study［J］. PLoS One, 2013, 8(4): e62487. ［6］ Klimstra DS, Modlin IR, Coppola D, et al. The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems［J］. Pancreas, 2010, 39(6): 707712. ［7］ Pape UF, Berndt U, MüllerNordhorn J, et al. Prognostic factors of longterm outcome in gastroenteropancreatic neuroendocrine tumours［J］. Endocr Relat Cancer, 2008,15(4): 10831097. ［8］ Lawrence B, Gustafsson BI, Kidd M, et al. The clinical relevance of chromogranin A as a biomarker for gastroenteropancreatic neuroendocrine tumors［J］. Endocrinol Metab Clin North Am, 2011, 40(1): 111314. ［9］ Dronamraju SS, Joypaul VB. Management of gastrointestinal carcinoid tumours  10 years experience at a district general hospital［J］. J Gastrointest Oncol, 2012, 3(2): 120129. ［10］ Gnanaseqaran G, O′Doherty MJ. Imaging neuroendocrine tumours with radionuclide techniques［J］. Minerva Endocrinol, 2008, 33(2):105126. ［11］中国胃肠胰神经内分泌肿瘤病理专家组.中国胃肠胰神经内分泌肿瘤病理学诊断共识［J］. 中华病理学杂志, 2011, 40(4): 257262. ［12］ Knigge U, Hansen CP. Surgery for GEPNETs［J］. Best Pract Res Clin Gastroenterol, 2012, 26(6): 819831. ［13］ Ahmed A, Turner G, King B, et al. Midgut neuroendocrine tumours with liver metastases: results of the UKINETS study［J］. Endocr Relat Cancer, 2009, 16(3): 885894. ［14］ Scherübl H, Jensen RT, Cadiot G, et al. Management of early gastrointestinal neuroendocrine neoplasms［J］. World J Gastrointest Endosc, 2011, 3(7): 133139. ［15］ Raymond E, Dahan L, Raoul JL, et al. Sunitinib malate for the treatment of pancreatic neuroendocrine tumors［J］. N Engl J Med, 2011, 364(6): 501513. ［16］ Ahn HK, Choi JY, Kim KM, et al. Phase Ⅱ study of pazopanib monotherapy in mentastatic gastroenteropancreatic neuroendocrine tumours［J］. Br J Cancer, 2013, 109(6): 14141419. ［17］ Yao JC, Shah MH, Ito T, et al. Everolimus for advanced pancreatic neuroendocrine tumors［J］. N Engl J Med, 2011, 364(6): 514523. ［18］ Strosberg J, Kvols L. Antiproliferative effect of somatostatin analogs in gastroenteropancreatic neuroendocrine tumors［J］. World J Gastroenterol, 2010, 16(24): 29632970. ［19］ Caplin ME, Pavel M, Cwikla JB, et al. Lanreotide in metastatic enteropancreatic neuroendocrine tumors［J］. N Engl J Med, 2014, 371(3): 224233. ［20］ Boudreaux JP, Klimstra DS, Hassan MM, et al. The NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: welldifferentiated neuroendocrine tumors of the Jejunum, Ileum, Appendix, and Cecum［J］. Pancreas, 2010, 39(6): 753766. ［21］ Castao JP, Sundin A, Maecke HR, et al. Gastrointestinal neuroendocrine tumors (NETs): new diagnostic and therapeutic challenges［J］. Cancer Metastasis Rev, 2014, 33(1): 353359. ［22］ Platanias LC. Mechanisms of typeⅠ and typeⅡinterferonmediated signaling［J］. Nat Rev Immunol, 2005, 5(5): 375386. ［23］ berg K, Knigge U, Kwekkeboom D, et al. Neuroendocrine gastroenteropancreatic tumors: ESMO Clinical Practice for diagnosis, treatment and followup［J］. Ann Oncol, 2012, 23 Suppl 7: vii124130. ［24］ Basu B, Sirohi B, Corrie P. Systemic therapy for neuroendocrine tumours of gastroenteropancreatic origin［J］. Endocr Relat Cancer, 2010, 17(1): R7590. ［25］ Casciano R, Wang X, Stern L, et al. International practice patterns and resource utilization in the treatment of neuroendocrine tumors［J］. Pancreas, 2013, 42(2): 339347. ［26］ Ramage JK, Ahmed A, Ardill J, et al. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)［J］. Gut, 2012, 61(1): 632.

[1]	高凡, 王萍, 杜超, 褚衍六.肠道菌群与结直肠癌非手术治疗的相关研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 376-381.
[2]	张蕊, 褚衍六.基于FIT与肠道菌群的结直肠癌风险评估模型的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 370-375.
[3]	过慈良, 江春平, 吴俊华.肠道菌群与肿瘤免疫治疗[J]. 国际肿瘤学杂志, 2023, 50(7): 432-436.
[4]	吕璐, 孙鹏飞.肠道菌群与宫颈癌[J]. 国际肿瘤学杂志, 2023, 50(6): 373-376.
[5]	石小琪, 汪红艳.肠道菌群与放射性肠炎的相互作用及研究进展[J]. 国际肿瘤学杂志, 2023, 50(4): 244-247.
[6]	罗澜, 陈创, 李昕倩, 孙圣荣.细菌与乳腺癌的关系[J]. 国际肿瘤学杂志, 2021, 48(5): 292-295.
[7]	纪莉, 王璐, 钱东华.胃肠道间质瘤肺转移一例[J]. 国际肿瘤学杂志, 2019, 46(2): 124-126.
[8]	万文泽，张睿智，李承果，杨文昶，王涛，曾祥宇，蔡明，王国斌，张鹏，陶凯雄.胃肠间质瘤术后伊马替尼辅助治疗停止后复发、转移的诊治分析[J]. 国际肿瘤学杂志, 2018, 45(11): 665-669.
[9]	朱玉萍, 李德川, 刘卓.青少年胃肠道间质瘤研究进展[J]. 国际肿瘤学杂志, 2014, 41(6): 447-450.
[10]	孙闻, 陈锦飞.胃肠间质瘤生物标志物改变与患者预后及靶向药物疗效的关系[J]. 国际肿瘤学杂志, 2012, 39(4): 295-298.
[11]	张怡安, 朱畴文.胃肠道间质瘤的预后评估[J]. 国际肿瘤学杂志, 2011, 38(5): 380-384.

胃肠道神经内分泌肿瘤的诊断和治疗进展

10.3760/cma.j.issn.1673-422X.2015.04.019

PDF

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章11

编辑推荐

Metrics

本文评价